Hydrix Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	4.4yrs
Board average tenure	6.5yrs

Recent management updates

Recent updates

CEO

Hydrix has no CEO, or we have no data on them.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Gavin Coote	Executive Chairman	7.3yrs	AU$667.60k	2.07% A$ 84.0k
Gareth Evans	Group Head of Finance	1.3yrs	no data	no data
Alyn Tai	Corporate Counsel & Company Secretary	7.9yrs	no data	no data
Alan Morris	Group Marketing Director	no data	no data	no data
Robert Brierley	Global Director of Human Resource	1.7yrs	no data	no data
John Bumgarner	Chief Research Officer	6.1yrs	no data	no data
Peter Lewis	Executive Vice President of Business Development	2.3yrs	AU$290.90k	no data
Paul Kelly	GM of Hydrix Medical & Member of Medical Advisory Board	4.4yrs	no data	no data
Stewart Washer	Specialist Biosciences Adviser & Member of Advisory Board	no data	no data	no data

4.4yrs

Average Tenure

Experienced Management: HYD's management team is considered experienced (4.4 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Gavin Coote	Executive Chairman	7.3yrs	AU$667.60k	2.07% A$ 84.0k
Alyn Tai	Corporate Counsel & Company Secretary	no data	no data	no data
Paul Kelly	GM of Hydrix Medical & Member of Medical Advisory Board	4.4yrs	no data	no data
Stewart Washer	Specialist Biosciences Adviser & Member of Advisory Board	no data	no data	no data
Paul Wright	Independent Non-Executive Director	5.8yrs	AU$58.00k	0.80% A$ 32.4k
Paul Lewis	Non-Executive Director	2.6yrs	AU$48.00k	6.52% A$ 265.3k
Glenn Ross	Member of Advisory Board	9.3yrs	AU$50.25k	no data
Julie King	Non-Executive Director	7.2yrs	AU$58.00k	10.33% A$ 420.4k

6.5yrs

Average Tenure

Experienced Board: HYD's board of directors are considered experienced (6.5 years average tenure).

Hydrix Management

Management criteria checks 2/4

Key information

Recent management updates

Hydrix Limited, Annual General Meeting, Nov 13, 2023

Less than half of directors are independent

Hydrix Limited, Annual General Meeting, Oct 11, 2022

Less than half of directors are independent

Recent updates

New major risk - Financial position

Hydrix Limited, Annual General Meeting, Nov 13, 2023

Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.032 loss in FY 2022)

New major risk - Share price stability

First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.015 loss in 1H 2022)

Hydrix Limited Announces TGA Response to Guardian Application

Hydrix Limited has completed a Derivatives Offering in the amount of AUD 0.252324 million.

Less than half of directors are independent

Full year 2022 earnings released: AU$0.032 loss per share (vs AU$0.068 loss in FY 2021)

Hydrix Limited, Annual General Meeting, Oct 11, 2022

Hydrix Limited Receives Singapore HSA Approval for Guardian Device

Less than half of directors are independent

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Hydrix Limited announced that it expects to receive AUD 2.828 million in funding

Health Check: How Prudently Does Hydrix (ASX:HYD) Use Debt?

Full year 2021 earnings released: AU$0.068 loss per share (vs AU$0.043 loss in FY 2020)

Hydrix Limited Completes TGA Submission for Angelmed Guardian System

Health Check: How Prudently Does Hydrix (ASX:HYD) Use Debt?

Hydrix (ASX:HYD) Has Debt But No Earnings; Should You Worry?

New 90-day low: AU$0.21

New 90-day low: AU$0.24

Earnings released

Hydrix Limited to Report Fiscal Year 2020 Results on Aug 26, 2020

New 90-day high - AU$0.32

Hydrix Limited has completed a Follow-on Equity Offering in the amount of AUD 1.990557 million.

Hydrix Limited announced that it expects to receive AUD 1 million in funding

CEO

Leadership Team

Average Tenure

Board Members

Average Tenure